Company intelligence / Profile preview
Link Health Group Ltd.
Guangzhou, Guangdong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Link Health Group Ltd. has multiple programs in Phase 1 and Phase 2 clinical trials, including small molecule drugs for oncology and osteoarthritis indications. No commercial products reported.
- Therapeutic areas
- OncologyRheumatology
- Modalities
- Small molecule drugCell therapy
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
George Clinical (joint venture: Link-George Clinical Research)
Beyond the preview
Go deeper on Link Health Group Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Link Health Group Ltd..